Company Overview of Albert Einstein College of Medicine
Albert Einstein College of Medicine is an educational institution.
1300 Morris Park Avenue
Jack and Pearl Resnick Campus
Bronx, NY 10461
Founded in 1984
Key Executives for Albert Einstein College of Medicine
Professor and Chairman of the Department of Cardiothoracic Surgery
Compensation as of Fiscal Year 2016.
Albert Einstein College of Medicine Key Developments
Albert Einstein College of Medicine and Montefiore in Collaboration with the City University of New York Receives $9.4 Million Grant from the National Institutes of Health
Aug 15 16
Albert Einstein College of Medicine and Montefiore, in collaboration with the City University of New York (CUNY), have received a $9.4 million grant from the National Institutes of Health (NIH) to lead research in Central Africa to improve clinical care and health outcomes for patients with HIV. The ongoing, five-country observational study, called Central Africa International Epidemiologic Databases to Evaluate AIDS (CA-IeDEA), involves more than 50,000 HIV-positive children and adults taking anti-retroviral therapy (ART). CA-IeDEA partners with the governments of five nations—Burundi, Cameroon, Rwanda, and the Democratic Republic of Congo—and will extend the collaboration to the Republic of Congo. Researchers and health workers based in each country regularly collect de-identified data from electronic medical records, which are integrated into an external database for analysis. Over the next five years, the team will increase the number of clinical sites involved in the study from 15 to 20 as CA-IeDEA expands into more rural areas.
Montefiore, Albert Einstein College of Medicine and Columbia University Medical Center Awards $3 Million for HIV Prevention
Jul 26 16
Researchers at Montefiore, Albert Einstein College of Medicine and Columbia University Medical Center, have been awarded nearly $3 million from the National Institute of Mental Health to increase the use of pre-exposure prophylaxis "a medication that reduces the risk of contracting HIV. The intervention will integrate PrEP into Montefiore primary care practices throughout the Bronx, a borough with one of the highest HIV rates in the nation. The selection of Montefiore Medical Group's Federally Qualified Health Centers (FQHCs) for this intervention highlights Montefiore's expertise in developing models for treating diseases on a population basis, and its ongoing collaboration with the New York City government to end the AIDS epidemic. The randomized trial will involve six Montefiore Medical Group FQHCs; three will receive the intervention, which will address diverse barriers to PrEP by: Training Montefiore primary care providers to prescribe and manage PrEP. Developing a PrEP Eligibility Tool that will help providers identify high-risk individuals who might be eligible for PREP. Making it simple for providers to use the electronic medical record to screen, prescribe, monitor and communicate with patients and other clinicians about PrEP. Appointing PrEP "champions" at each site to serve as role models to support provider colleagues in talking with patients about their sexual health. Identifying high-risk individuals in collaboration with BOOM!Health, a Bronx-based community organization that conducts HIV testing and outreach. It will link people to primary care providers who can offer PrEP.
Jiangsu Hengrui Medicine Announce Collaboration with Albert Einstein College of Medicine to Advance Cancer Research and Drug Discovery
Apr 25 16
Jiangsu Hengrui Medicine Co., Ltd. announced that they have entered into a research agreement with Albert Einstein College of Medicine (Einstein) to advance cancer treatment. The multi-year cancer research agreement brings together the scientific and clinical capabilities of Einstein and Jiangsu Hengrui Medicine to develop innovative cancer therapies. The immediate goal of this research is to discover new targets and develop therapies in oncology space.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries